The great disappearing act: Bone marrow receiver cured of allergy

November 08, 2013

BALTIMORE, MD. (November 8, 2013) - Not only can bone marrow transplants be life-saving for children with acute lymphocytic leukemia, they may also cure peanut allergies. According to research presented during the American College of Allergy, Asthma and Immunology's (ACAAI) Annual Scientific Meeting, a 10-year-old boy no longer had a peanut allergy after undergoing a bone marrow transplant.

"It has been reported that bone marrow and liver transplants can transfer peanut allergy from donor to recipient," said allergist Yong Luo, MD, Ph.D., ACAAI member and lead study author. "But our research found a rare case in which a transplant seems to have cured the recipient of their allergy."

At 15 months of age, researchers noted the child had been diagnosed with a peanut allergy after experiencing whole body hives and vomiting following peanut ingestion. At age 10, he underwent a bone marrow transplant for leukemia, from a donor with no known allergies. Soon after, the child seemed to no longer have an allergy to peanuts. Allergists confirmed with an oral food challenge, which should only be done in an allergist's office, where the child ate a small amount of peanut and showed no allergic reaction.

"Food allergy is associated with the body's abnormal production of high specific IgE levels," said Steven Weiss, MD, Ph.D., ACAAI fellow and study author. "This case, in addition to the previous reports, indicates that genetic modification during the early stages of immune cell development in bone marrow may play a large role in causing allergy."

Peanut allergy is one of the most common types of food allergies. According to ACAAI, it is the most prevalent food allergen among school-aged children in the United States, affecting about 400,000. Unlike an allergy to milk or soy, peanut allergy tends to last a lifetime.

Children with peanut allergy should always carry prescribed epinephrine. Even if a parent thinks their child may no longer have an allergy, proper testing should be done by a board-certified allergist to confirm if the child is still sensitive to any particular allergens.

"Food allergies are serious and can cause a severe, life-threatening reaction known as anaphylaxis," said Dr. Weiss. "It's important to be under the regular care of an allergist who can perform proper tests and administer treatment."
-end-
The ACAAI Annual Meeting is being held Nov. 7-11 at the Baltimore Convention Center in Baltimore. For more news and research being presented at the meeting, follow the conversation on Twitter #ACAAI.

About ACAAI

The ACAAI is a professional medical organization of more than 5,700 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyAndAsthmaRelief.org. Join us on Facebook, Pinterest and Twitter.

American College of Allergy, Asthma, and Immunology

Related Leukemia Articles from Brightsurf:

New therapeutic approach against leukemia
Using an RNA molecule complex, researchers can prevent retention of cancer stem cell in their tumor supporting niche

Nanoparticle for overcoming leukemia treatment resistance
One of the largest problems with cancer treatment is the development of resistance to anticancer therapies.

Key gene in leukemia discovered
Acute myeloid leukemia (AML) is one of the most common forms of blood cancer among adults and is associated with a low survival rate, and leads to the inhibition of normal blood formation.

Vitamin B6, leukemia's deadly addiction
Researchers from CSHL and Memorial Sloan Kettering Cancer Center have discovered how Acute Myeloid Leukemia is addicted to vitamin B6.

Artificial intelligence tracks down leukemia
Artificial intelligence can detect one of the most common forms of blood cancer - acute myeloid leukemia -- with high reliability.

Milestone reached in new leukemia drug
Using a chemical compound called YKL-05-099, a team of cancer researchers from CSHL and the Dana Farber Institute was able to target the Salt-Inducible Kinase 3 (SIK3) pathway and extend survival in mice with MLL leukemia.

The drug combination effective against bovine leukemia
Scientists have succeeded in reducing levels of the bovine leukemia virus (BLV) in cows with severe infections by combining an immune checkpoint inhibitor and an enzyme inhibitor.

Towards a safer treatment for leukemia
An international team of researchers at VIB-KU Leuven, Belgium, the UK Dementia Institute and the Children's Cancer Institute, Australia, have found a safer treatment for a specific type of leukemia.

Research paves way for new source for leukemia drug
Chemistry researchers have patented a method for making anti-leukemia compounds that until now have only been available via an Asian tree that produces them.

An atlas of an aggressive leukemia
A team of researchers led by Bradley Bernstein at the Ludwig Center at Harvard has used single-cell technologies and machine learning to create a detailed 'atlas of cell states' for acute myeloid leukemia (AML) that could help improve treatment of the aggressive cancer.

Read More: Leukemia News and Leukemia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.